Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin β1-driven Src-Akt bypass signaling
Crossref DOI link: https://doi.org/10.1038/onc.2016.407
Published Online: 2016-10-31
Published Print: 2017-05-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Y-J
Jung, K
Baek, D-S
Hong, S-S
Kim, Y-S
Text and Data Mining valid from 2016-10-31
Version of Record valid from 2016-10-31
Article History
Received: 28 May 2016
Revised: 7 September 2016
Accepted: 23 September 2016
First Online: 31 October 2016
Competing interests
: The authors declare no conflict of interest.